Home Press Release Minimally Invasive Surgeries Market Size Projected to Reach $166.26 billion by 2034 | 7.8%

Minimally Invasive Surgeries Market Size Projected to Reach $166.26 billion by 2034 | 7.8%

23 Jul, 2026

According to Straits Research, the global minimally invasive surgeries market size was valued at $84.57 billion in 2025 and is expected to grow from $91.17 billion in 2026 to $166.26 billion by 2034, registering a CAGR of 7.8% during the forecast period 2026–2034.

A major growth driver of the global minimally invasive surgeries (MIS) market is the increasing elderly population, which faces a higher risk of chronic conditions such as cancer, heart disease, and orthopedic ailments. MIS procedures are particularly suitable for older patients as they offer benefits like quicker recovery, shorter hospital stays, and minimal scarring. The widespread development of outpatient and ambulatory surgical centers (ASCs) has also boosted the accessibility of these surgeries, thanks to their affordability and ease of service.

In addition, continual advancements in technology—such as improved surgical navigation systems, cutting-edge imaging technologies, and energy-based devices—have significantly increased the precision and safety of MIS procedures. Innovations like high-definition 3D visualization and sophisticated laparoscopic instruments enable surgeons to handle complex operations more effectively. Moreover, supportive reimbursement frameworks and favorable government initiatives, especially in North America and Europe, are accelerating the transition from traditional open surgeries to minimally invasive methods.

Market Dynamics

Rising prevalence of lifestyle-related disorders drives the global market

The growing incidence of lifestyle-related health conditions is a major factor propelling the global minimally invasive surgeries (MIS) market. Disorders such as obesity, type 2 diabetes, cardiovascular ailments, and gallstones are becoming increasingly prevalent due to sedentary lifestyles, poor dietary habits, and rising stress levels. These conditions often necessitate surgical procedures, and MIS offers a safer, less invasive, and faster recovery alternative compared to traditional open surgeries.

  • As reported by the World Obesity Federation in 2024, global obesity is projected to affect over 1 billion individuals by 2030. Furthermore, the World Health Organization notes that the number of people living with diabetes worldwide has surged from 200 million in 1990 to 830 million in 2022, with estimates suggesting it will reach 853 million by 2050. 

These alarming trends are fueling demand for minimally invasive procedures, such as laparoscopic bariatric surgeries and cardiac interventions, solidifying MIS as a vital response to today’s evolving healthcare needs.

Innovation in single-incision and natural orifice transluminal endoscopic surgeries (NOTES) creates tremendous opportunities

One of the most significant growth opportunities in the global minimally invasive surgeries (MIS) market is the evolution of single-incision techniques and natural orifice transluminal endoscopic surgery (NOTES). These advanced approaches are designed to reduce visible scarring, shorten recovery times, and improve overall patient outcomes. The integration of robotic technologies is further enhancing the precision and viability of these procedures.

  • For example, a March 2025 study published in MDPI assessed the use of robot-assisted vNOTES in complex gynecological surgeries such as endometriosis excision. The findings indicated that the approach is feasible and less invasive, with an overall complication rate of 17.5% (2.1% intraoperative and 15.4% postoperative), highlighting its potential with cautious application.

As the demand for ultra-minimally invasive techniques continues to grow, companies that focus on developing advanced robotic systems compatible with NOTES are well-positioned to gain traction in both emerging and established healthcare markets.

Regional Analysis

North America dominates the global minimally invasive surgeries (MIS) market due to its advanced healthcare infrastructure, high adoption of surgical robotics, and growing elderly population. The U.S. sees a high volume of laparoscopic, orthopedic, and cardiovascular MIS procedures, driven by the rising incidence of obesity and joint disorders. According to the American Joint Replacement Registry (AJRR), over 1.4 million knee and hip replacements were performed in 2023, with a significant share using minimally invasive techniques. 

Additionally, the FDA’s approval of Intuitive Surgical’s next-gen da Vinci robotic system in 2024 has accelerated robotic-assisted MIS adoption across top U.S. hospitals. Canada is also witnessing growth with increased funding for outpatient surgical centers. The surge in ambulatory surgery centers and insurance coverage for MIS in both countries further cements North America's leadership, making it a hub for innovation, training, and deployment of cutting-edge MIS technologies.

Market Segments

  1. By Device Type:
    1. Surgical Instruments
    2. Forceps, Scissors
    3. Trocars
    4. Dilators and Retractors
    5. Sutures and Staplers
    6. Endoscopic Devices
    7. Rigid and Flexible Endoscopes
    8. Monitoring and Visualization Systems
    9. Laparoscopes
    10. Cameras
    11. Light Sources
    12. Robotic Surgical Systems
    13. Insufflators
    14. Electrosurgical Devices
    15. Handheld Instruments
    16. Ablation and Energy Devices
  2. By Procedure 
    1. Laparoscopic Surgery
    2. Robotic Surgery
    3. Endoscopic Mucosal Resection
    4. Endoscopic Sub-mucosal Dissection
    5. Needle-Based Surgery
    6. Arthroscopic Surgery
    7. Percutaneous Surgery
    8. Others
  3. By Application 
    1. Cardiac Surgery
    2. Gastrointestinal Surgery
    3. Orthopedics and Spine Surgery
    4. Gynecological Surgery
    5. Thoracic Surgery
    6. Cosmetic Surgery
    7. Others
  4. By End-User 
    1. Hospital
    2. Surgical Clinics
    3. Ambulatory Surgical Centers (ASCs)
    4. Others